263 related articles for article (PubMed ID: 25628444)
1. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
[TBL] [Abstract][Full Text] [Related]
2. Potential Drug-Drug and Herb-Drug Interactions in Patients With Cancer: A Prospective Study of Medication Surveillance.
Ramos-Esquivel A; Víquez-Jaikel Á; Fernández C
J Oncol Pract; 2017 Jul; 13(7):e613-e622. PubMed ID: 28628392
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
4. Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation.
Rodrigues J; Marques P; Gomes C; Portela C
Cureus; 2023 Feb; 15(2):e35324. PubMed ID: 36994248
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
[TBL] [Abstract][Full Text] [Related]
6. Real-world prevalence of potential drug-drug interactions involving oral antineoplastic agents: a population-based study.
Kim SH; Suh Y; Ah YM; Jun K; Lee JY
Support Care Cancer; 2020 Aug; 28(8):3617-3626. PubMed ID: 31802250
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
8. Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method.
van Leeuwen RW; Swart EL; Boom FA; Schuitenmaker MS; Hugtenburg JG
BMC Cancer; 2010 Dec; 10():679. PubMed ID: 21144049
[TBL] [Abstract][Full Text] [Related]
9. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
[TBL] [Abstract][Full Text] [Related]
11. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
[TBL] [Abstract][Full Text] [Related]
13. Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.
Benoist GE; van Oort IM; Smeenk S; Javad A; Somford DM; Burger DM; Mehra N; van Erp NP
Br J Clin Pharmacol; 2018 Jan; 84(1):122-129. PubMed ID: 28881501
[TBL] [Abstract][Full Text] [Related]
14. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
[TBL] [Abstract][Full Text] [Related]
16. Interaction between phytotherapy and oral anticancer agents: prospective study and literature review.
Clairet AL; Boiteux-Jurain M; Curtit E; Jeannin M; Gérard B; Nerich V; Limat S
Med Oncol; 2019 Apr; 36(5):45. PubMed ID: 30993543
[TBL] [Abstract][Full Text] [Related]
17. Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study.
Schlichtig K; Dürr P; Dörje F; Fromm MF
Clin Pharmacol Ther; 2021 Oct; 110(4):1075-1086. PubMed ID: 34118065
[TBL] [Abstract][Full Text] [Related]
18. Potentially Hazardous Drug-Drug Interactions Associated With Oral Antineoplastic Agents Prescribed in Chinese Tertiary Care Teaching Hospital Settings: A Multicenter Cross-Sectional Study.
Wang H; Shi H; Wang Y; Wang N; Li Y; Yang Q; Li Y; Liu C; Zan Y; Feng S; Xie J
Front Pharmacol; 2022; 13():808848. PubMed ID: 35177990
[No Abstract] [Full Text] [Related]
19. Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.
van Leeuwen RWF; le Comte M; Reyners AKL; van den Tweel A; van Vlijmen B; Kwee W; Wensveen B; Steeghs N; Visser O; van Gelder T; Jansman FGA
Semin Oncol; 2022 Apr; 49(2):119-129. PubMed ID: 35397932
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of potential drug-drug interactions in patients with castration-resistant prostate cancer treated with abiraterone acetate.
Jamani R; Lee EK; Berry SR; Saluja R; DeAngelis C; Giotis A; Emmenegger U
Eur J Clin Pharmacol; 2016 Nov; 72(11):1391-1399. PubMed ID: 27561266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]